Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis

Frank Kloprogge; Lesley Workman; Steffen Borrmann; Mamadou Tekete; Gilbert Lefevre; Kamal Hamed; Patrice Piola; Johan Ursing; Poul Erik Kofoed; Andreas Martensson; Billy Ngasala; Anders Bjorkman; Michael Ashton; Sofia Friberg Hietala; Francesca Aweeka; Sunil Parikh; Leah Mwai; Timothy ME Davis; Harin Karunajeewa; Sam Salman; Francesco Checchi; Carole Fogg; Paul N Newton; Mayfong Mayxay; Philippe Deloron; Jean Francois Faucher; Francois Nosten; Elizabeth A Ashley; Rose McGready; Michele van Vugt; Stephane Proux; Ric N Price; Juntra Karbwang; Farkad Ezzet; Rajesh Bakshi; Kasia Stepniewska; Nicholas J White; Philippe J Guerin; Karen Barnes; Joel Tarning

Journal article

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis

Frank Kloprogge, Lesley Workman, Steffen Borrmann, Mamadou Tekete, Gilbert Lefevre, Kamal Hamed, Patrice Piola, Johan Ursing, Poul Erik Kofoed, Andreas Martensson, Billy Ngasala, Anders Bjorkman, Michael Ashton, Sofia Friberg Hietala, Francesca Aweeka, Sunil Parikh, Leah Mwai, Timothy ME Davis, Harin Karunajeewa, Sam Salman Show all

PLOS Medicine | PUBLIC LIBRARY SCIENCE | Published : 2018

DOI: 10.1371/journal.pmed.1002579

University of Melbourne Researchers

Harin Karunajeewa Author Medical Biology (W.E.H.I.)

Grants

Awarded by Wellcome Trust of Great Britan

Awarded by Bill & Melinda Gates Foundation

Funding Acknowledgements

The Mahidol-Oxford Tropical Medicine Research Unit is partly funded by the Wellcome Trust of Great Britan (106698/Z/14/Z). The WorldWide Antimalarial Resistance Network is funded by a Bill & Melinda Gates Foundation grant (OPP1181807 started October 2017 and OPP1099191 ended in Sept 2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.